Literature DB >> 22670566

Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits.

Daniel A Rasbach1, Andrew J Desruisseau, Aaron M Kipp, Samuel Stinnette, Asghar Kheshti, Bryan E Shepherd, Timothy R Sterling, Todd Hulgan, Catherine C McGowan, Han-Zhu Qian.   

Abstract

Clarifying the relationship between illicit drug use and HIV-1 virologic suppression requires characterization of both illicit drug use activity and adherence to antiretroviral therapy (ART). We developed a rapid clinical questionnaire to assess prior 7-day illicit drug use and ART adherence in a cross-sectional study among 1777 HIV-infected persons in care. Of these, 76% were male, 35% were African-American, and 8% reported injection drug use as their probable route of HIV-1 infection. Questionnaire-reported frequencies of cocaine and marijuana use within the previous 7 days were 3.3% and 12.1%, respectively. Over three quarters (77.8%) of participants were on ART, of whom 69.7% had HIV-1 virologic suppression (HIV-1 RNA<48 copies/mL). Univariate analyses revealed that compared to no use, cocaine and marijuana use were both associated with missed ART doses (P<0.01). Multivariable logistic regression analysis adjusting for nonadherence demonstrated that cocaine use was independently associated with failing to achieve virologic suppression (adjusted odds ratio (aOR): 0.46; 95% confidence interval (95% CI): 0.22-0.98) but marijuana use was not (aOR: 1.08; 95% CI: 0.72-1.62). This result strengthens the evidence of a direct effect of cocaine on virologic control, independent of nonadherence to ART.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670566      PMCID: PMC3443534          DOI: 10.1080/09540121.2012.687814

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  40 in total

Review 1.  Definition and epidemiology of late presentation in Europe.

Authors:  Margaret Johnson; Caroline Sabin; Enrico Girardi
Journal:  Antivir Ther       Date:  2010

2.  Comparison of antiretroviral adherence questions.

Authors:  Karina M Berg; Ira B Wilson; Xuan Li; Julia H Arnsten
Journal:  AIDS Behav       Date:  2012-02

3.  Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.

Authors:  M P Nair; K C Chadha; R G Hewitt; S Mahajan; A Sweet; S A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  The relationship between injection and noninjection drug use and HIV disease progression.

Authors:  Han-Zhu Qian; Samuel E Stinnette; Peter F Rebeiro; Aaron M Kipp; Bryan E Shepherd; Charles P Samenow; Cathy A Jenkins; Paul No; Catherine C McGowan; Todd Hulgan; Timothy R Sterling
Journal:  J Subst Abuse Treat       Date:  2011-02-23

5.  Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy.

Authors:  Aaron M Kipp; Andrew J Desruisseau; Han-Zhu Qian
Journal:  J Subst Abuse Treat       Date:  2011-02-24

6.  Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment.

Authors:  L M Bogart; J A Kelly; S L Catz; J M Sosman
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-15       Impact factor: 3.731

7.  Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine.

Authors:  O Bagasra; R J Pomerantz
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

8.  Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty?

Authors:  Ira B Wilson; Amanda E Carter; Karina M Berg
Journal:  Curr HIV/AIDS Rep       Date:  2009-11       Impact factor: 5.071

9.  Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care.

Authors:  Amy C Weintrob; Greg A Grandits; Brian K Agan; Anuradha Ganesan; Michael L Landrum; Nancy F Crum-Cianflone; Erica N Johnson; Claudia E Ordóñez; Glenn W Wortmann; Vincent C Marconi
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

10.  Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts.

Authors:  Catherine C McGowan; David D Weinstein; Charles P Samenow; Samuel E Stinnette; Gema Barkanic; Peter F Rebeiro; Timothy R Sterling; Richard D Moore; Todd Hulgan
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

View more
  22 in total

1.  Marijuana use and viral suppression in persons receiving medical care for HIV-infection.

Authors:  Chukwuemeka N Okafor; Zhi Zhou; Larry E Burrell; Natalie E Kelso; Nicole E Whitehead; Jeffery S Harman; Christa L Cook; Robert L Cook
Journal:  Am J Drug Alcohol Abuse       Date:  2016-07-11       Impact factor: 3.829

2.  Do Symptoms of Depression Interact with Substance Use to Affect HIV Continuum of Care Outcomes?

Authors:  Anthony T Fojo; Catherine R Lesko; Keri L Calkins; Richard D Moore; Mary E McCaul; Heidi E Hutton; William C Mathews; Heidi Crane; Katerina Christopoulos; Karen Cropsey; Michael J Mugavero; Kenneth Mayer; Brian W Pence; Bryan Lau; Geetanjali Chander
Journal:  AIDS Behav       Date:  2019-03

3.  Daily Marijuana Use is Associated with Missed Clinic Appointments Among HIV-Infected Persons Engaged in HIV Care.

Authors:  Aaron M Kipp; Peter F Rebeiro; Bryan E Shepherd; Lauren Brinkley-Rubinstein; Megan Turner; Sally Bebawy; Timothy R Sterling; Todd Hulgan
Journal:  AIDS Behav       Date:  2017-07

4.  Design and Development of a Risk Classification Instrument for Virological Failure in HIV, Using Psychosocial Determinants of Health: Preliminary Evidence from a South American Country.

Authors:  Angela J Pereira-Morales; Diana Acero Torres; Mary Moreno Zapata; Pedro Moreno Sierra; Jhon Astaiza Hurtado
Journal:  AIDS Behav       Date:  2021-02

5.  Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-Cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV.

Authors:  James T Lee; Lauren A Saag; Aaron M Kipp; James Logan; Bryan E Shepherd; John R Koethe; Megan Turner; Sally Bebawy; Timothy R Sterling; Todd Hulgan
Journal:  AIDS Behav       Date:  2020-04

6.  Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: Results of the LINK LA clinical trial.

Authors:  David Goodman-Meza; Steve Shoptaw; Robert E Weiss; Terry Nakazono; Nina T Harawa; Sae Takada; Wendy H Garland; William E Cunningham
Journal:  Drug Alcohol Depend       Date:  2019-07-16       Impact factor: 4.492

7.  Cocaine enhances HIV-1-induced CD4(+) T-cell apoptosis: implications in disease progression in cocaine-abusing HIV-1 patients.

Authors:  Jui Pandhare; Amma B Addai; Chinmay K Mantri; Cynthia Hager; Rita M Smith; Louis Barnett; Fernando Villalta; Spyros A Kalams; Chandravanu Dash
Journal:  Am J Pathol       Date:  2014-01-31       Impact factor: 4.307

8.  Health Literacy and Demographic Disparities in HIV Care Continuum Outcomes.

Authors:  Peter F Rebeiro; Tristan D McPherson; Kathryn M Goggins; Megan Turner; Sally S Bebawy; William B Rogers; Lauren Brinkley-Rubinstein; Anna K Person; Timothy R Sterling; Sunil Kripalani; April C Pettit
Journal:  AIDS Behav       Date:  2018-08

9.  Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.

Authors:  Raquel B De Boni; Bryan E Shepherd; Beatriz Grinsztejn; Carina Cesar; Claudia Cortés; Denis Padgett; Eduardo Gotuzzo; Pablo F Belaunzarán-Zamudio; Peter F Rebeiro; Stephany N Duda; Catherine C McGowan
Journal:  AIDS Behav       Date:  2016-11

Review 10.  Substance use in older HIV-infected patients.

Authors:  E Jennifer Edelman; Jeanette M Tetrault; David A Fiellin
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.